Shionogi & Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Gross-Profit" stands at 372.91 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.
Shionogi & Co. Ltd.'s second quarter result of 95.76 Billion JPY for the item "Gross Profit" represents an increase of 9.48 percent compared to it's first quarter result.
Also, Shionogi & Co. Ltd.'s second quarter result of 95.76 Billion JPY for the item "Gross Profit" represents a decrease of -3.87 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Shionogi & Co. Ltd.'s second quarter result of 372.91 Billion JPY for the item "Gross Profit" represents a decrease of -1.02 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 4.61 percent compared to the value the year prior.
The 1 year change in percent is 4.61.
The 3 year change in percent is 30.83.
The 5 year change in percent is 39.26.
The 10 year change in percent is 84.67.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Gross Profit | 905,699,262,464.00 |
![]() | Johnson & Johnson - Gross Profit | 486,508,953,600.00 |
![]() | AbbVie Inc - Gross Profit | 399,570,305,024.00 |
![]() | Roche Holding AG - Gross Profit | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Gross Profit | 280,205,508,085.11 |